FDA Enforcement History: OPS International Inc dba Olympia Pharmaceuticals

FDA action counts

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. OPS International Inc dba Olympia Pharmaceuticals has 1 FDA event on file. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Enforcement history

On 2026-09-03, Argus HQ recorded an FDA Form 483 inspection citation for OPS International Inc dba Olympia Pharmaceuticals, rated "high" severity in Argus HQ's classification: OPS International Inc dba Olympia Pharmaceuticals -- FDA 483: 8 observations (2026-09-03). Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Frequently asked questions

Does Argus HQ track new FDA actions for OPS International Inc dba Olympia Pharmaceuticals automatically?

Yes. Argus HQ ingests FDA sources daily, including FDA warning letters, recalls, drug and biologic approvals, and Form 483 inspection observations. When a new FDA action linked to OPS International Inc dba Olympia Pharmaceuticals is observed, this page's event count and history update automatically.

How many FDA actions does Argus HQ track for OPS International Inc dba Olympia Pharmaceuticals?

1 total: 0 warning letters, 0 recalls, 0 approval records, and 1 Form 483 inspection citation.

What is the most recent FDA action on file for OPS International Inc dba Olympia Pharmaceuticals?

September 3, 2026. Argus HQ ingests new FDA enforcement records daily.

Is this FDA enforcement data for OPS International Inc dba Olympia Pharmaceuticals official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

Related enforcement actions

• OPS International Inc dba Olympia Pharmaceuticals -- FDA 483: 8 observations (2026-09-03) →

Compare with

• OPS International Inc dba Olympia Pharmaceuticals vs Medline Industries, LP
• OPS International Inc dba Olympia Pharmaceuticals vs Philips North America
• OPS International Inc dba Olympia Pharmaceuticals vs Boston Scientific Corporation
• OPS International Inc dba Olympia Pharmaceuticals vs Baxter Healthcare Corporation
• OPS International Inc dba Olympia Pharmaceuticals vs PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.